Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

MS-based label-free quantification of the ratio of AIFM1/AK2 peptide intensities from CTRL or IA-treated FLAG pull-downs

ABSTRACT: This project aims to utilize mass spectrometry (MS) for label-free quantification of the peptide intensity ratio of AIFM1 (Apoptosis-Inducing Factor Mitochondrion-Associated 1) and AK2 (Adenylate Kinase 2) in control (CTRL) and iodoacetamide (IA)-treated FLAG pull-down samples. The approach focuses on analyzing the variations in peptide intensities to understand the differential protein interactions and modifications resulting from IA treatment.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Cell Culture

SUBMITTER: Fabian Schildhauer

LAB HEAD: Juri Rappsilber

PROVIDER: PXD052852 | Pride | 2025-05-06

REPOSITORIES: Pride

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	B230402_02_Lumos_DS_IN_120_4h_CTRL1_ID_DIA_rep1.raw	Raw
	B230402_02_Lumos_DS_IN_120_4h_CTRL1_ID_DIA_rep1.raw.quant	Raw
	B230402_03_Lumos_DS_IN_120_4h_CTRL1_ID_DIA_rep2.raw	Raw
	B230402_03_Lumos_DS_IN_120_4h_CTRL1_ID_DIA_rep2.raw.quant	Raw
	B230402_04_Lumos_DS_IN_120_4h_CTRL1_ID_DIA_rep3.raw	Raw

Items per page:

1 - 5 of 51

Similar Datasets

AK2 deficiency affects human hematopoiesis

Project description:Reticular dysgenesis (RD) is a human Severe Combined Immunodeficiency mainly characterized by a profound neutropenia and lymphopenia. This pathology is due to mutations in the adenylate kinase 2 (AK2) gene, resulting in the loss of AK2 protein expression. AK2 is a mitochondrial protein, which regulates the homeostasis of cellular adenine nucleotides by converting ADP into ATP and AMP. Using a RNA interference strategy, we dissected the role of AK2 during the commitment of hematopoietic progenitors towards the lymphoid or myeloid lineage. Our results demonstrated that AK2 knock-down progenitors have reduced proliferative and survival capacity and differentiation toward the lymphoid or granulocytic lineage is abrogated. In this report, we also highlighted that AK2 signaling pathway is essential to control energy production and to maintain the integrity of all mitochondrial functions. This steady state may be disturbed in RD patients leading to a blockade of the differentiation process.

2015-06-21 | E-MTAB-2680 | biostudies-arrayexpress

RNA-seq of granulocytes derived from control and AK2 depleted human HSPCs

Project description:Reticular Dysgenesis (RD) is a rare but devastating form of severe combined immunodeficiency, characterized by a maturation arrest of the myeloid and lymphoid lineages paired with sensorineural hearing loss. RD is caused by biallelic loss-of-function mutations in the mitochondrial enzyme adenylate kinase 2 (AK2). To study the effect of AK2 depletion on HSPC differentiation, we developed a biallelic AK2 CRISPR knock-out model using human HSPCs. AK2 depleted HSPCs display severe proliferation and myeloid differentiation defects, recapitulating RD patient phenotype.

2021-07-06 | GSE179320 | GEO

Human AK2 links intracellular bioenergetic redistribution to the fate of hematopoietic progenioptors

Project description:Recent studies have linked bioenergetic regulation to cellular differentiation. However, the contribution of metabolic communication among subcellular components to the fate of progenitor cells remains unclear. Adenylate kinase 2 (AK2) is an adenylate phosphotransferase localized in the mitochondrial intermembrane space. Although AK2 mutations in human can cause a severe combined immunodeficiency with neutropenia, named reticular dysgenesis (RD), underlying mechanisms have not yet been elucidated. To address these questions, we established induced pluripotent stem cells (iPSCs) from two RD patients. Metabolic flux analysis revealed that AK2 mediates the distribution of glycolytic metabolites into the tricarbon acid cycle in mitochondria. Hematopoietic differentiation from RD-iPSCs was profoundly impaired. Intriguingly, RD-iPSC-derived hematopoietic progenitors exhibited an immature mitochondrial morphology, discordant ATP distribution among the mitochondria and nucleus, and alteration of global transcriptional profiles. These results highlight the importance of stage-specific intracellular energy communication for controlling the fate of multipotential progenitors.

2018-09-03 | GSE76761 | GEO

Pull-downs of non-crosslinked or in-cell SDA crosslinked FLAG-AK2-transfected 293 cells

Project description:Human cells were transfected with a plasmid encoding FLAG-AK2 and subsequently treated with a photoactivatable crosslinker, SDA, or left untreated. Pulldowns were performed from these cells, and the bead-bound material was digested and subjected to LC-MS DIA runs for analysis.

2025-05-06 | PXD052867 | Pride

AK2 promotes the migration and invasion of lung adenocarcinoma by activating TGF-β/Smad pathway in vitro and in vivo

Project description:Adenylate kinase 2 (AK2) is a wide-spread and highly conserved protein kinase whose main function is to catalyze the exchange of nucleotide phosphate groups. In this study, we showed that AK2 regulated tumor cell metastasis in lung adenocarcinoma. Positive expression of AK2 is related to lung adenocarcinoma progression and poor survival of patients. Knockdown or knockout of AK2 inhibited, while overexpression of AK2 promoted, human lung adenocarcinoma cell migration and invasion ability. Differential proteomics results showed that AK2 might be closely related to epithelial-mesenchymal transition (EMT). Further research indicated that AK2 regulated EMT occurrence through the Smad-dependent classical signaling pathways as measured by western blot and qPCR assays. Additionally, in vivo experiments showed that AK2-knockout in human lung tumor cells reduced their EMT-like features and formed fewer metastatic nodules both in liver and in lung tissues. In conclusion, we uncover a cancer metastasis-promoting role for AK2 and provide a rationale for targeting AK2 as a potential therapeutic approach for lung cancer.

2021-09-18 | PXD028247 | Pride

Marinilabilia nitratireducens strain:AK2

Project description:Marinilabilia nitratireducens strain:AK2 Genome sequencing

| PRJNA157957 | ENA

Complexome profiling of human mitochondrial proteins

Project description:Protein complexes from isolated and crosslinked human mitochondria were separated using BN-PAGE. The gel lanes were then divided into 20 slices each, with each slice subsequently digested. The resulting peptides were analyzed, and the data from DIA runs were utilized for complexome profiling of mitochondrial complexes, including AIFM1, AK2, other proteins, and OXPHOS complexes.

2025-05-06 | PXD052821 | Pride

AK2 promotes the migration and invasion of lung adenocarcinoma by activating TGF-β/Smad pathway in vitro and in vivo

2021-09-09 | PXD028231 |

Interaction with AK2 establishes AIFM1 as organizing platform in mitochondria

Project description:Interactome of overexpressed, HA-tagged AIFM1 in HEK293T AIFM1 KO background vs control (3797, 3593), Interactome of overexpressed, HA-tagged AIFM1 variants in HEK293T AIFM1 KO background vs control (3859), Comparison of whole cell extract after gelfiltration of HEK293T AIFM1 KO cell line vs WT

2025-08-04 | PXD055617 | Pride

DPP8/9 processing of human AK2 unmasks an IAP binding motif

Project description:AK2 is n-terminally processed by methionine aminopeptidases, N-terminal acetylation and DDP8/9 to become an active protein which is then sorted in the mitochondrial intermembrane space. We used peptide pull-downs of free and acetylated N-terminal peptides of AK2 from the different processing steps to identify binding partners by MS. We identified the inhibitor of apoptosis E3 ligase proteins (IAPs; BIRC2, 3, 6 and XIAP) as new binding partners for processed AK2 and show that they are responsible for AK2 degradation in the cytosol.

2025-03-13 | PXD047178 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data